Medicinal Chemistry of Alternative Therapeutics: Novelty and Hopes with Genus Ammannia

2019 ◽  
Vol 19 (10) ◽  
pp. 784-794 ◽  
Author(s):  
Harish C. Upadhyay
Keyword(s):  
Traditional Medicine ◽  
Biological Activities ◽  
World Health ◽  
Biologically Relevant ◽  
Traditional Medicines ◽  
Drug Molecules ◽  
Health Organization ◽  
Tract Infections ◽  
Pharmacologically Active ◽  
Herbal Formulations

The plants have formed the basis of folklore remedy since the beginning of human civilization. The cumulative human endeavor and experience over a period of thousands of years developed into well to organize traditional medicine systems viz. Ayurvedic, Unani, Chinese amongst others. Across the world, traditional medicine is either the mainstay of health care or serves as a complement to modern drugs. In view of worldwide use of traditional medicines, World Health Organization launched ‘WHO-Traditional Medicine Strategy 2014-2023’ for the development of strong policies regarding knowledge-base, safety, quality-control and effectiveness of traditional/alternative therapeutics for national health systems. Besides their use in traditional medicine, plants have always been a good source of modern drug/pharmacologically active molecules. More than half of the modern pharmaceuticals are either plant isolates or their derivatives. The plant-based drugs are not only effective, but have better compatibility with human biological systems because of more biologically relevant chemistry, hence lesser side effects. Some of the species of genus Ammannia (Lythraceae) have been reported for their magical medicinal values. Many herbal formulations containing Ammannia spp. have been patented for treatment of serious diseases/disorders like cancer, spinal disease, human female infertility, chronic tonsillitis, pelvic inflammatory disease, treatment of bladder stones, urinary tract infections, dermatitis etc. The uses of Ammannia spp. in traditional medicine have been further verified by the biological activities of their extracts as well as isolation of bioactive phytomolecules. The current review provides details about Ammannia spp.; its use in folklore remedy, herbal formulations, biological activities of extracts, isolation of bioactive phytomolecules and SAR study of semi-synthetic derivatives to analyze the possibility of new drug molecules of plant origin.

scholarly journals Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery

Biology ◽  
2020 ◽  
Vol 9 (9) ◽  
pp. 252 ◽  
Author(s):  
Ngan Tran ◽  
Bao Pham ◽  
Ly Le
Keyword(s):  
Diabetes Mellitus ◽  
Traditional Medicine ◽  
World Health Organization ◽  
Morphological Data ◽  
World Health ◽  
Hypoglycemic Agents ◽  
Antidiabetic Activity ◽  
Insulin Production ◽  
Traditional Medicines ◽  
Health Organization

Natural products, including organisms (plants, animals, or microorganisms) have been shown to possess health benefits for animals and humans. According to the estimation of the World Health Organization, in developing countries, 80% of the population has still depended on traditional medicines or folk medicines which are mostly prepared from the plant for prevention or treatment diseases. Traditional medicine from plant extracts has proved to be more affordable, clinically effective and relatively less adverse effects than modern drugs. Literature shows that the attention on the application of phytochemical constituents of medicinal plants in the pharmaceutical industry has increased significantly. Plant-derived secondary metabolites are small molecules or macromolecules biosynthesized in plants including steroids, alkaloids, phenolic, lignans, carbohydrates and glycosides, etc. that possess a diversity of biological properties beneficial to humans, such as their antiallergic, anticancer, antimicrobial, anti-inflammatory, antidiabetic and antioxidant activities Diabetes mellitus is a chronic disease result of metabolic disorders in pancreas β-cells that have hyperglycemia. Hyperglycemia can be caused by a deficiency of insulin production by pancreatic (Type 1 diabetes mellitus) or insufficiency of insulin production in the face of insulin resistance (Type 2 diabetes mellitus). The current medications of diabetes mellitus focus on controlling and lowering blood glucose levels in the vessel to a normal level. However, most modern drugs have many side effects causing some serious medical problems during a period of treating. Therefore, traditional medicines have been used for a long time and play an important role as alternative medicines. Moreover, during the past few years, some of the new bioactive drugs isolated from plants showed antidiabetic activity with more efficacy than oral hypoglycemic agents used in clinical therapy. Traditional medicine performed a good clinical practice and is showing a bright future in the therapy of diabetes mellitus. World Health Organization has pointed out this prevention of diabetes and its complications is not only a major challenge for the future, but essential if health for all is to be attained. Therefore, this paper briefly reviews active compounds, and pharmacological effects of some popular plants which have been widely used in diabetic treatment. Morphological data from V-herb database of each species was also included for plant identification.

Urinary Tract Infections: Characterization and Herbal Antimicrobial Activity: A Review

2017 ◽  
Vol 8 (02) ◽  
Author(s):  
Imad Hadi Hameed ◽  
Abeer Fauzi Al-Rubaye ◽  
Mohanad Jawad Kadhim
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
World Health ◽  
World Population ◽  
Main Stream ◽  
Human Society ◽  
Care Needs ◽  
Traditional Medicines ◽  
Health Organization ◽  
Tract Infections

Medicinal plants are part and parcel of human society to combat diseases from the dawn of civilization. According to World Health Organization (WHO), about 80% of the world population rely chiefly on plant based traditional medicine specially for their primary health care needs and there has been a worldwide move towards the use of traditional medicines due to concerns over the more invasive, expensive and potentially toxic main stream practices. This review gives a bird’s eye view on the updated information on urinary tract infections (UTIs), different categories of urologic herbs, historical use and modern scientific investigations on some important urologic herbs, clinical studies, some isolated chemical compounds and their possible side effects.

scholarly journals Iranian Medicinal Plants: From Ethnomedicine to Actual Studies

Medicina ◽  
2020 ◽  
Vol 56 (3) ◽  
pp. 97
Author(s):  
Piergiacomo Buso ◽  
Stefano Manfredini ◽  
Hamid Reza Ahmadi-Ashtiani ◽  
Sabrina Sciabica ◽  
Raissa Buzzi ◽  
...  
Keyword(s):  
Traditional Medicine ◽  
Early Stage ◽  
New Drugs ◽  
World Health ◽  
Traditional Medicines ◽  
Traditional Iranian Medicine ◽  
Wide Range ◽  
The World ◽  
History Of ◽  
Health Organization

Iran has a rich and diverse cultural heritage, consisting of a complex traditional medicine deeply rooted in the history of the territory that goes back to the Assyrian and Babylonian civilizations. The ethnomedical practices that can be identifiable nowadays derive from the experience of local people who have developed remedies against a wide range of diseases handing down the knowledge from generation to generation over the millennia. Traditional medicine practices represent an important source of inspiration in the process of the development of new drugs and therapeutic strategies. In this context, it is useful to determine the state of the art of ethnomedical studies, concerning the Iranian territory, and of scientific studies on plants used in traditional Iranian medicine. Data regarding 245 plants used in Iranian ethnomedical practices and scientific studies conducted on 89 plants collected in the Iranian territory have been reported. All of the scientific studies here reported draw inspiration from traditional medicine. The World Health Organization (WHO) has repeatedly called for an intensification of the scientific validation processes of traditional medicines intended as an important contribution to public health in various parts of the world. The process of study and validation of Iranian ethnomedical practices appears to be at an early stage.

A short review on important drugs under clinical trial against Covid-19

2020 ◽  
Vol 21 ◽  
Author(s):  
Namita Misra
Keyword(s):  
Respiratory Illness ◽  
Short Review ◽  
World Health ◽  
Upper Respiratory Tract ◽  
Suspected Infection ◽  
Medicinal Treatment ◽  
Travel Restrictions ◽  
Personal Level ◽  
Health Organization ◽  
Tract Infections

: Corona virus spreads from one to other person, either by touching the hands or by touching the surface contaminated with this virus, and then touching the nose or mouth. Covid-19 infected human symptoms are like any pneumonia symptoms, dry cough and high fever. Upper respiratory tract infections symptoms and sore throat are rare. First notified in china dated 12th December 2019 as a respiratory illness. In addition to travel restrictions and quarantine measures everyone should follow the World Health Organization advice guidelines on the management of humans infected with known or suspected infection with SARS-CoV-2 virus at the personal level. The development of vaccine or medicines for the same are under progress and this short review will summarize the most potential candidates such as Remdesivir, Lopinavir and Ritonavir, Chloroquine, Hydroxychloroquine, Hydroxychloroquine with Azithromycin, Favipiravir, Umifenovir, and Ribavirin for its medicinal treatment.

scholarly journals Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel

2020 ◽  
Vol 15 (5) ◽  
pp. 540-554 ◽  
Author(s):  
Adnan I Qureshi ◽  
Foad Abd-Allah ◽  
Fahmi Al-Senani ◽  
Emrah Aytac ◽  
Afshin Borhani-Haghighi ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Current Knowledge ◽  
Intravenous Thrombolysis ◽  
Adult Patients ◽  
World Health ◽  
Stroke Patients ◽  
International Panel ◽  
Health Organization ◽  
Tract Infections

Background and purpose On 11 March 2020, World Health Organization (WHO) declared the COVID-19 infection a pandemic. The risk of ischemic stroke may be higher in patients with COVID-19 infection similar to those with other respiratory tract infections. We present a comprehensive set of practice implications in a single document for clinicians caring for adult patients with acute ischemic stroke with confirmed or suspected COVID-19 infection. Methods The practice implications were prepared after review of data to reach the consensus among stroke experts from 18 countries. The writers used systematic literature reviews, reference to previously published stroke guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate practice implications. All members of the writing group had opportunities to comment in writing on the practice implications and approved the final version of this document. Results This document with consensus is divided into 18 sections. A total of 41 conclusions and practice implications have been developed. The document includes practice implications for evaluation of stroke patients with caution for stroke team members to avoid COVID-19 exposure, during clinical evaluation and performance of imaging and laboratory procedures with special considerations of intravenous thrombolysis and mechanical thrombectomy in stroke patients with suspected or confirmed COVID-19 infection. Conclusions These practice implications with consensus based on the currently available evidence aim to guide clinicians caring for adult patients with acute ischemic stroke who are suspected of, or confirmed, with COVID-19 infection. Under certain circumstances, however, only limited evidence is available to support these practice implications, suggesting an urgent need for establishing procedures for the management of stroke patients with suspected or confirmed COVID-19 infection.

scholarly journals Role of Chest Imaging in Viral Lung Diseases

2021 ◽  
Vol 18 (12) ◽  
pp. 6434
Author(s):  
Diletta Cozzi ◽  
Eleonora Bicci ◽  
Alessandra Bindi ◽  
Edoardo Cavigli ◽  
Ginevra Danti ◽  
...  
Keyword(s):  
Lung Diseases ◽  
Respiratory Tract Infections ◽  
Laboratory Data ◽  
World Health ◽  
Pulmonary Manifestations ◽  
Radiological Patterns ◽  
Health Organization ◽  
Tract Infections ◽  
Combining Information

The infection caused by novel beta-coronavirus (SARS-CoV-2) was officially declared a pandemic by the World Health Organization in March 2020. However, in the last 20 years, this has not been the only viral infection to cause respiratory tract infections leading to hundreds of thousands of deaths worldwide, referring in particular to severe acute respiratory syndrome (SARS), influenza H1N1 and Middle East respiratory syndrome (MERS). Although in this pandemic period SARS-CoV-2 infection should be the first diagnosis to exclude, many other viruses can cause pulmonary manifestations and have to be recognized. Through the description of the main radiological patterns, radiologists can suggest the diagnosis of viral pneumonia, also combining information from clinical and laboratory data.

scholarly journals Analysis of the interventions adopted due to the COVID-19 on ARI morbility for Colombia

2020 ◽  
Author(s):  
Alvaro Quijano-Angarita ◽  
Oscar Espinosa ◽  
Marcela M Mercado-Reyes ◽  
Diana Walteros ◽  
Diana Carolina Malo
Keyword(s):  
Respiratory Infections ◽  
Age Groups ◽  
World Health ◽  
Health Concern ◽  
Surveillance Systems ◽  
Highly Correlated ◽  
Health Organization ◽  
Tract Infections ◽  
Official Declaration

Acute Respiratory Infections are among the leading causes of death globally, particularly in developing countries, and are highly correlated with the quality of health and surveillance systems and effective early interventions in high-risk age groups. According to the World Health Organization, about four million people die each year from mostly preventable respiratory tract infections, making it a public health concern. The official declaration of a pandemic in March 2020 due to the Sars-CoV-2 virus coincided with the influenza season in Colombia and with environmental alerts about low air quality that increase its incidence. The objective of this document is the application of a flexible model for the identification of the pattern and monitoring of ARI morbility for Colombia by age group that shows atypical patterns in the reported series for 5 departments and that coincide with the decisions implemented to contain the COVID-19

Investigation of the physicochemical and pharmacognostical properties of Anzaroot (The manna of Astragalus sarcocola Dymock.) according to the World Health Organization

2020 ◽  
Vol 42 (5) ◽  
pp. 564-571
Author(s):  
Hadi Esmaeeli ◽  
Ali Davoodi ◽  
Masoud Azadbakht ◽  
Mohammad Azadbakht
Keyword(s):  
Traditional Medicine ◽  
World Health Organization ◽  
Pharmaceutical Products ◽  
Water Soluble ◽  
World Health ◽  
Flavonoid Content ◽  
Therapeutic Properties ◽  
The Common ◽  
Health Organization ◽  
Scientific Name

Background: Anzaroot is a manna produced from Astragalus sarcocola Dymock (Family Leguminosae) that is widely distributed in Fars, Kerman, Baluchestan and Hormozgan in Iran. Since the study of the physicochemical properties and quality control (QC) of herbal materials results in the validation and standardization for clinical uses, in accordance with World Health Organization (WHO) guidelines, it is necessary to carry out for Anzaroot which has indication in traditional medicine. Methods: Anzaroot was identified and determinated scientific name by a systematic specialist after purchasing from Niak pharmaceutical co. in gorgan. Physicochemical and pharmacognostical properties of Anzaroot have been determinated According to the WHO guidlines. Results: Anzaroot is a very bitter, crisp and fragile manna and non-stick in dry state, which is seen as separate binary grains under the microscope. The moisture content, foreign matter, sucrose content, total ash and water-soluble ash were reported 5.25 ± 0.2, 2.8 ± 0.2, 12.09 ± 0.04, 9.8 ± 0.5 and 2.9±0.15, respectively. It has significant foaming index, 72% Solublity in water and less than 50% in 96% ethanol and not swelling index. The levels of lead, mercury and cadmium were 0.0006, 0.0002 and 0.0007 ppm and total flavonoid content was reported 18.61 μg/ml with respect to standard Quercetin at 415 nm. Conclusion: This study can be a novel idea for the discovery or development of pharmaceutical products based on Anzaroot of Iran and its diverse therapeutic properties, such as the common cold, contusion, and bone fracture in traditional medicine.

Traditional Medicine

2021 ◽  
pp. 118-129
Author(s):  
Pavitra Solanki ◽  
Yasmin Sultana ◽  
Satyavir Singh
Keyword(s):  
At Risk ◽  
Antimicrobial Resistance ◽  
Traditional Medicine ◽  
Volatile Oil ◽  
World Health ◽  
Antibiotic Resistant ◽  
Life Saving ◽  
The World ◽  
History Of ◽  
Health Organization

Everybody is at risk of being infected by drug-resistant microscopic organisms. Managing with sickness has never been less demanding within the history of our species. At the current rate of antimicrobial resistance (AMR) in microbes, specialists foresee that battling infections tuberculosis, HIV, and intestinal sickness will become more complicated. Antimicrobial resistance is rendering numerous life-saving drugs useless. Antibiotic-resistant microbes, known as “superbugs,” are getting to be more various and more harmful, thanks to the proceeding abuse of anti-microbials. Natural medication offers an alternative to these progressively ineffectual drugs. According to the World Health Organization (WHO), traditional medicine is a holistic term enclosing diverse health practices. Concurring to a report by the College of Maryland Therapeutic Center, turmeric's volatile oil serves as a common anti-microbial.

Sign in / Sign up

Export Citation Format

Share Document